Ruff P. Vorobiof D.A. Jordaan J.P. Demetriou G.S. Moodley S.D. Nosworthy A.L. Werner I.D. Raats J. Burgess L.J.
(2009)
Purpose: To determine if concomitant administration of docetaxel plus zosuquidar.3HC1 can prolong progression-free survival in patients with metastatic breast cancer. Methods: A randomized, double-blind, multicenter, ...